Fig. 1. Basal syndecan-1 (A ) and heparan sulfate (B ) release in coronary venous effluent of hearts during the 10 min perfusion period without (group A) or after pretreatment with 0.5 (group B) or 1 MAC sevoflurane (group C) and the respective release following 20 min warm (37°C) no-flow ischemia without (group J) or with pretreatment (group K, 0.5 MAC and group L, 1 MAC sevoflurane). * I/R versus Control groups (A, B, and C; P < 0.01 each), I/R + Sevo 0.5 MAC and I/R + Sevo 1 MAC (P < 0.05 each). #I/R + Sevo 1 MAC versus I/R; I/R + Sevo 0.5 MAC (P < 0.05 each) and Control groups (A, B, and C; P < 0.01 each). §I/R + Sevo 0.5 MAC versus I/R (P < 0.05) and Control groups (A, B, and C; P < 0.01 each). I/R = ischemia/reperfusion; MAC = minimal alveolar concentration; Sevo = sevoflurane.